Senior insider sale
Chief Financial Officer at AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$203.9K
14.79K shares
What this filing means
FRATES JAMES M plans to sell 14.79K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $203.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001235598-26-000002
Officer· Chief Financial Officer
Since Jan 2022
14.79K
Shares to sell
$203.9K
Approx. market value
22.52K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
N/A
3/2/2026
22.52KTotal acquired22.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units N/A | 22.52K | — |
| Total | 22.52K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.56K
Market value
$52.1K
2/2/2026
—Completed
Units to sell
3.33K
Market value
$37.0K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.91K
Market value
$114.9K
3/2/2026
Total
Units
14.79K
Value
$203.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 3.56K | $52.1K | — | Completed |
1/6/2026 | 3.33K | $37.0K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 7.91K | $114.9K | NASDAQ | Planned |
| Total | 14.79K | $203.9K | ||